CBD Life Sciences (CBD Life Sciences) Additional Paid-In Capital : $1.17 Mil(As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Additional Paid-In Capital?

CBD Life Sciences's quarterly additional paid-in capital stayed the same from Mar. 2015 ($1.17 Mil) to Jun. 2015 ($1.17 Mil) and stayed the same from Jun. 2015 ($1.17 Mil) to Sep. 2015 ($1.17 Mil).

CBD Life Sciences's annual additional paid-in capital stayed the same from Dec. 2012 ($0.37 Mil) to Dec. 2013 ($0.37 Mil) but then increased from Dec. 2013 ($0.37 Mil) to Dec. 2014 ($0.98 Mil).

CBD Life Sciences Additional Paid-In Capital Historical Data

The historical data trend for CBD Life Sciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Additional Paid-In Capital Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Additional Paid-In Capital

0.37

0.98

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Additional Paid-In Capital	Get a 7-Day Free Trial											0.85	0.98	1.17	1.17	1.17

CBD Life Sciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

CBD Life Sciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.